Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Chemoradiotherapy in Head and Neck Cancer
NCT02902432Phase 2Unknown
- Sponsor
- China International Medical Foundation
- Start
- Jun 2016
- Primary completion
- Dec 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in squamous cell carcinoma of the head and neck (HNSCC), sponsored by China International Medical Foundation. Status: unknown.
02
Drugs
endostar
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02902432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02902432.